Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04473612
Other study ID # DF0091UG
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 20, 2020
Est. completion date September 1, 2020

Study information

Verified date October 2020
Source Universidad de Granada
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Inside of studies that report an upper airway function impaired, the upper limb strength has been demonstrated to be determinant in breath, speech and swallow performance. Nevertheless, no previous studies in neuromuscular disease have explored the relation between general disability and upper airway function.

There is a suspicion of upper airway which is associated with physical deterioration, however the extent to which if feeds back has not been explored.


Recruitment information / eligibility

Status Completed
Enrollment 41
Est. completion date September 1, 2020
Est. primary completion date August 15, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Years to 65 Years
Eligibility Inclusion Criteria:

- Diagnosis of Neuromuscular disease

- Between 6 and 65 years

- Impairment of the upper airway

- Accepted to sign the informed consent

Exclusion Criteria:

- Cognitive impairment.

- Diagnose of autism spectrum disorder or severe intellectual disability

- Physical or functional impairment that limits the performance of evaluation

Study Design


Locations

Country Name City State
Spain University of Granada Granada

Sponsors (1)

Lead Sponsor Collaborator
Universidad de Granada

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Hand grip strength Hand grip strength will be evaluated with a pressure dynamometer according to the protocol, to their maximum ability in a seated position . The average of three attempts for the dominant hand will be recorded.
It has been proven that it can be used as an indicator of general health and as a strong predictor of future mortality, disability, falls, complications and resource utilization.
Baseline
Primary Respiratory function Respiratory function will be evaluated with spirometry following standardized protocols. Collected variables will be Forced Expiratory Volume in the First Second (FEV1), Forced Vital Capacity (FVC) and Maximal Voluntary Ventilation (MVV). Baseline
Primary Peak expiratory flow Peak expiratory flow is a person's maximum speed of expiration, as measured with a peak flow meter, a small, hand-held device used to monitor a person's ability to breathe out air. It will be measured following standardized protocols. Baseline
Secondary European Quality of Life-5 Dimensions (EQ-5D) The perception of the level of health and the quality of life were evaluated with the questionnaire European Quality of Life-5 Dimensions (EQ-5D). It is composed of 2 parts in which health status is assessed:
Descriptive system: It consists on 5 dimensions that include mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Patients classify their health status in 3 severity levels: having no problems, having some or moderate problems, being unable to do/having extreme problems.
Visual Analog Scale, by which respondents can report their perceived health status with a grade ranging from 0 (the worst possible health status) to 100 (the best possible health status).
Baseline
Secondary Fatigue Severity Scale Fatigue severity scale (FSS) will be used to measure fatigue. It consists of 9 items with answers that the patient scores between 1 and 7. The total is calculated by adding all the items. For children will be used The PedsQL™ Multidimensional Fatigue Scale, which is composed of 18 items comprising 3 dimensions (general fatigue, sleep/rest fatigue, cognitive fatigue), evaluated thorough a Liker scale with values from 0 (never) to 4 (almost always), referring to difficulty presented. Baseline
Secondary World Health Organization Disability Assessment Scale (WHODAS) 2.0 (WD2) To measure the degree of disability, the World Health Organization Disability Assessment Scale, WHODAS 2.0 (WD2) will be used. It measures changes in functioning and levels of difficulty in carrying out and carrying out its activities . The WD2 scale is composed of 36 items divided into 6 domains, evaluated through a Likert scale with values from 1 to 5, referring to the difficulty presented. Higher scores show a greater degree of disability. Baseline
Secondary Activity Limitations in Children and Adults With Neuromuscular Disorders (ACTIVLIM) The Activity Limitations in Children and Adults With Neuromuscular Disorders (ACTIVLIM) questionnaire is an instrument to measure functional limitation and has been calibrated in children and adults with neuromuscular diseases, according to the difficulty of patients to perform daily activities that require the use of the upper extremities and / or lower. Baseline
Secondary Brief pain inventory For pain assessment we will use a specific brief pain questionnaire, Brief Pain Inventory , which consists of three parts. In the first, the patient will indicate in a drawing the area in which he presents this pain. The second part refers to the pain felt in the last days, where it is scored, as in the previous questionnaire, from 0 to 10 (0 being no pain and 10 being the maximum pain felt). Finally, in a third part we see how that pain influences the different activities that the patient performs in his day to day. Baseline
Secondary Hospital Anxiety and Depression Scale Anxiety and depression will be assessed with the Hospital Anxiety and Depression Scale (HADS) . This scale is composed of 14 items divided into two subscales, 7 items of anxiety and 7 items of depression, involving higher values worse psycho-emotional state. Baseline
Secondary Muscle strength of the neck To evaluate the muscle strength of the neck in neuromuscular patients, neck dynamometry will be performed. With subtests in which front bending, extension, pure lateral flexion, lateral flexion with rotation and pure rotation were measures. Baseline
Secondary Eating Assessment Tool-10 (EAT-10) The EAT-10 is a self-administered instrument that evaluate specific symptoms of dysphagia with 10 items and each item have a range from zero (no problem to swallow) to four (a serious problem for life).
In the case of patients pediatric with dysphagia it used Pediatric Eating Assessment Tool (PEDI-EAT-10)
Baseline
Secondary Swallowing quality of life questionnaire (SWAL-QOL) To measure the possible swallowing problems in daily life we will used the SWAL-QOL, it contains 44 items and each item was scored from zero (the worst state) to four (the best state) . This questionnaire consists of 44 items, consisting of 11 subscales. With a Likert type score in which the patient scores between 1 and 5. Where 1 indicates the worst state and 5 the most favorable. Baseline
Secondary Functional Oral Intake Scale (FOIS) questionnaire The severity of swallowing will be assessed using the Functional Oral Intake Scale (FOIS) questionnaire . This scale consists of 7 levels, with 1 being the most severe and 7 being the least severe, the patient has to select the level with which he is. Baseline
Secondary Karaduman Chewing Performance Scale (KCPS) There are also questionnaires like Karaduman Chewing Performance Scale (KCPS) , that permitted us evaluate the function of chewing, this test has not been used in previous studies in adults, so in this study we have only used it in the childrens patients. Baseline
Secondary Orofacial Myofunctional Evaluation with Scores (OMES) Clinical evaluation of the orofacial myofunctional condition will be evaluated using the Orofacial Myofunctional Evaluation with Scores (OMES) . It consisting of 4 subscales: appearance and posture, mobility and functions (breathing, deglutition, mastication). The examiner attributed scores on a 3 point scale: 3=normal, 2= insufficient ability; and 1= absence of ability or being unable to perform the task. Baseline
Secondary Volume Viscosity Clinical Exploration Method (MECV-V) Volume Viscosity Clinical Exploration Method (MECV-V) , this test provides us with information about the volume to which the 5ml, 10ml and 20 ml patients are able to feed and tells us what viscosity, nectar, liquid and pudding. It is used in the diagnosis of oropharyngeal dysphagia. Baseline
Secondary Voice handicap index (VHI-30) The phonatory function and it´s repercussion on daily life will be evaluated by the Voice handicap index (VHI-30) . This scale consists of 30 items, consisting of 3 subscales, functional, physical and emotional. In which the patient must indicate the presence or symptoms of dysphonia with a Likert type score of 5 points, in which 0 indicates never and 4 always indicates. Baseline
Secondary Grade, Roughness, Breathing, Asthenia, Effort (GRBAS) Perceptual scale of Grade, Roughness, Breathing, Asthenia, Effort (GRBAS) . Will be used to analyze qualitative aspects of the voice, it is completed by the evaluator who qualifies as: 0 normal, 1 mild, 2 moderate, 3 severe, each quality of the voice (Degree of dysphonia, scratchy, blown, weak or asthenic, tight or strangled). Baseline
Secondary Functional evaluation of the voice The functional evaluation of the voice will allow us to measure the intensity, frequency and duration of the voice: To evaluate the intensity of the voice, measured in decibels (dB), we will use a sound level meter; To evaluate the frequency of the voice , measured in Hz (Hz), we use the PRAAT software (Praat from the Dutch "speak"). In addition, the duration of the phonation and breathing times , measured in Sg, will be evaluated, for this we use an audio recorder. Baseline
See also
  Status Clinical Trial Phase
Completed NCT03305731 - Activating Behavior for Lasting Engagement After Stroke N/A
Not yet recruiting NCT05975476 - Comparison of Two Park-Based Activities on Emotional Well-Being in Adults With Mobility Impairments N/A
Completed NCT02604082 - Comparison of Three Technical Airway Clearance in Mechanical Ventilated Patients N/A
Completed NCT01472263 - Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases Phase 3
Completed NCT01417585 - A Trial of a Client-centered Intervention Aiming to Improve Functioning in Daily Life After Stroke N/A
Recruiting NCT06331858 - The Effect of Adding Instrumented Hip Concentric Abductor Strengthening Exercise in Knee Osteoarthritis N/A
Completed NCT04956705 - Vitamin D and Calcium Supplementation at Danish Nursing Homes N/A
Recruiting NCT05516030 - HIFT for People With Mobility-Related Disabilities N/A
Recruiting NCT04591574 - ABC - A Post Intensive Care Anaemia Management Trial N/A
Completed NCT04562662 - Evaluation of mediVR-KAGURA Guided Therapy N/A
Terminated NCT03696082 - A Precision Rehabilitation Approach to Counteract Age-Related Cognitive Declines N/A
Completed NCT04433962 - Investigation of the Effects of Balance Training on Balance and Functional Status Patients With Total Hip Arthroplasty N/A
Completed NCT03545932 - Self-perception of Health Status and Physical Condition of Elderly People Practitioners of Hydrogymnastics N/A
Not yet recruiting NCT06264362 - Developing a Nonpharmacological Pain Intervention for Community-dwelling Older Adults With Dementia N/A
Completed NCT02592265 - Measuring Consequences of Disability for Patients With Multiple Sclerosis and Caregivers on Economic Burden N/A
Completed NCT02926313 - The Effectiveness of Specialist Seating Provision for Nursing Home Residents N/A
Completed NCT02110290 - Effects of an Adapted Ski/Snowboarding Program on Quality of Life in Children With Physical Disabilities
Active, not recruiting NCT01646632 - Exercise Intervention in Institutionalized Elderly People Phase 2
Completed NCT00164476 - Promoting Clinical Preventive Services Among Adults With Disabilities Phase 1
Completed NCT02082171 - Multidomain Intervention to Prevent Disability in Elders N/A